ST Pharm has agreed a $56 million API supply deal with a US biotech for oligonucleotide therapeutics, boosting its order backlog and reflecting strong demand for advanced API manufacturing in global ...

QMM principles and practices can positively influence a sustainable drug supply and bolster the bottom-line of drug manufacturers, API suppliers, and CMO/CDMOs. Disclaimer: This article was not ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

Manufacturers and contract development and manufacturing organizations are developing processes and facilities to meet growing specialty API demand. For decades, APIs, the foundation of the ...

In the midst of Amarin’s activist investor blowout with Sarissa Capital Management, the company has a new battle brewing. In a new antitrust suit, generics maker Hikma has accused Amarin of ...

Indian API (Active Pharmaceutical Ingredient) manufacturers have remained in focus ever since the start of the pandemic. China's supply disruption earlier and rising API prices thereafter have ...